Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.
about
Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidaseInvolvement of substance P and the NK-1 receptor in human pathology.Analysis of nucleotide-binding oligomerization domain proteins in a murine model of pneumococcal meningitis.Neuroimmune pathways in alcohol consumption: evidence from behavioral and genetic studies in rodents and humansSubstance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis.Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.Investigating the role of MRGPRC11 and capsaicin-sensitive afferent nerves in the anti-influenza effects exerted by SLIGRL-amide in murine airways.Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathologyThe Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS DisordersAprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.Treatment of bacterial meningitis: an update.Substance P and the regulation of inflammation in infections and inflammatory bowel disease.Translational potential of astrocytes in brain disorders.Transmission pathways and mediators as the basis for clinical pharmacology of pain.Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.Substance P participates in immune-mediated hepatic injury induced by concanavalin A in mice and stimulates cytokine synthesis in Kupffer cells.Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.Neuro-Immune Mechanisms of Anti-Cryptococcal Protection.
P2860
Q34162782-EE7CF6A9-20BC-4A27-B60F-5F0DE5423F51Q34413850-7779B959-09C1-4F1A-AAD3-02DE862A8D45Q34636441-45177783-1ED7-4BA1-B9FB-3B0E5E119D4DQ34687635-782AB520-7D0B-491E-A1D8-B2A302B58DC3Q36218650-1E842293-4652-42EF-8EFD-C89683889346Q36416842-6155E2F2-4CA2-45D7-AA08-975192B5481BQ36925594-6C77CA9C-A2EF-455B-BC8D-C74E8ACE802CQ36929568-13A5FF8D-2563-4A0E-A0EB-53EC460FFFD1Q37302953-C6EF12A8-B487-4130-9E4B-5DB224510B74Q37553389-1E237CAF-7F02-49EF-A4C8-FA33B4D9FDA6Q37645422-E4655C30-EFAE-43C2-80AD-7E4DAB9CCF62Q38044024-046FFEFF-6A6C-4D77-8EFE-62F93561EF05Q38271424-89BAD362-EEFA-455F-A393-5A6A937514A1Q38589482-5F2634D9-CAE0-433E-B149-BBD4C355BD9AQ38870522-738E91AE-242F-47F8-8209-6E42F9F457A4Q40085168-ED28AE35-34F0-40E6-B33D-98E7B3BD2002Q42963185-A81F6D5A-8DDB-4B70-9F55-E662837C0E77Q47119077-5949B563-7980-4445-B315-BFB9F9862456Q48163368-87C93D09-D715-4363-BD4C-2788C3364907
P2860
Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@ast
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@en
type
label
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@ast
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@en
prefLabel
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@ast
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@en
P2093
P2860
P356
P1476
Prophylactic and therapeutic t ...... el of pneumococcal meningitis.
@en
P2093
Ian Marriott
John M Kluttz
Kenneth L Bost
Vinita S Chauhan
P2860
P304
P356
10.4049/JIMMUNOL.1100721
P407
P577
2011-05-11T00:00:00Z